<DOC>
	<DOC>NCT02840760</DOC>
	<brief_summary>The purpose of this study is to explore the therapeutic effect and mechanism of transcranial magnetic stimulation (rTMS) in the treatment of the tardive dyskinesia.</brief_summary>
	<brief_title>Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.</brief_title>
	<detailed_description />
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<criteria>The diagnosis of schizophrenia according to DSMIV； At least two item of Abnormal Involuntary Movement Scale（AIMS） must be 2 points or higher these symptoms are not from Parkinson，tourette's syndrome,huntington disease Signed an informed consent rTMS contraindications: intracranial metal substance, with heart pacemakers and cochlear implants, intracranial pressure patients to be diagnosed according to DSMIV for substance abused, development delayed current treatment with anticonvulsant acting drugs such as anticonvulsants, benzodiazepines Acute risk of suicide and impulse history of epileptic seizures or the presence of epileptic activity documented on the basis of EEG pregnant and lactant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>tardive dyskinesia.</keyword>
	<keyword>rTMS</keyword>
</DOC>